483 filings
Page 20 of 25
8-K
464nr 1zzno
6 Aug 08
Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates
12:00am
8-K
v5ukrllb cydeo1
24 Jul 08
Regulation FD Disclosure
12:00am
8-K
ay2o 2b5gjm
14 Jul 08
Entry into a Material Definitive Agreement
12:00am
8-K
hde6y
9 Jun 08
Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato®Loxapine) for Acute Agitation
12:00am
S-8
svsszhqyc1c5kckhp4h5
30 May 08
Registration of securities for employees
12:00am
8-K
inzdsf 8zcblib
30 May 08
Departure of Directors or Principal Officers
12:00am
8-K
zmjbq1
16 May 08
Regulation FD Disclosure
12:00am
8-K
yajhmtqjf6
12 May 08
Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates
12:00am
8-K
4vzkw 73nm8doy
30 Apr 08
Regulation FD Disclosure
12:00am
ARS
usn723kgvf6g37 rsxy
28 Apr 08
Annual report to shareholders
12:00am
UPLOAD
1kqilw3uovjv4cm kpnp
18 Apr 08
Letter from SEC
12:00am
8-K
5hnoyve69m1q 6jcjib
16 Apr 08
Departure of Directors or Principal Officers
12:00am
424B2
aglyyd4d
31 Mar 08
Prospectus for primary offering
12:00am
8-K
ot8gz
31 Mar 08
Entry into a Material Definitive Agreement
12:00am
424B5
sfher66
26 Mar 08
Prospectus supplement for primary offering
12:00am
8-K
g8bwsvlbqjusi5ux933q
26 Mar 08
Alexza Completes $10 Million Equity Financing with Bio*One Capital to Initiate Commercial Manufacturing in Singapore
12:00am
8-K
q83n8vrxw64 tlkfsou9
17 Mar 08
Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
12:00am